Value
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 8.3 |
| P/S | 8.0 |
| EV/EBITDA | 5.0 |
| Fwd P/E | 7.6 |
| PEG | 10.0 |
| Analyst target | 3.0 |
- ▸Forward P/E: 16.3x
- ▸PEG: 0.00
AFL · Why this verdict
Why AFLAC (AFL) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score5.8/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
Aflac is a high-margin life insurer with strong peer-relative quality and positive momentum, but the stock already trades 14.8% above the analyst target and 53% of exposure sits in Japan, so upside is limited.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Aflac sustains strong margins of 27%, ranking best-in-class among peers, which supports durable earnings power. Quality breakdown | Net and operating margins stay near 27% over the next 12 months, keeping the peer quality rank high. | →Stable |
| CounterMargins on insurance books can be flattered by investment gains and reserve releases, and revenue is already declining 1%, so margins may not be repeatable. | ||
Geographic concentration in Japan at 53.0% ties results to one economy and currency, making a single-market shock the main risk to earnings. Bear case | Japan share of the business should not rise further and results should hold up through yen and Japanese rate moves. | ↑Improving |
| CounterJapan is a mature, stable insurance market where Aflac has long operated, so the concentration may be a feature of its franchise rather than a flaw. | ||
The share price of $123.89 sits above the $105.6 analyst target, a 14.8% overshoot, leaving no valuation upside and a negative reward-to-risk of -1.32. Estimated upside | For the stock to justify its price, analyst targets must be raised toward or above the current price within 12 months. | →Stable |
| CounterAnalyst targets lag price in strong rallies and forward P/E of 16.3x is not extreme for a high-quality insurer, so targets may simply be revised up. | ||
Momentum is positive with rising on-balance volume and price above the 200-day average, but RSI of 73 and a price 4.9% from the 52-week high signal an extended move. Momentum breakdown | Price holds above the 200-day average through a normal pullback without RSI-driven reversal. | ↓Deteriorating |
| CounterOverbought readings often precede mean reversion, especially when the price already exceeds the analyst target. | ||
Insiders sold about $76.0M over 90 days across 86 sales with zero purchases, a bearish signal despite being only 0.122% of market cap. Net value 90d | Insider selling should taper and not accelerate as the stock sits near its highs. | →Stable |
| CounterLarge sales count may reflect routine pre-scheduled compensation selling and the amount is tiny relative to market cap. | ||
Aflac sustains strong margins of 27%, ranking best-in-class among peers, which supports durable earnings power.
→StableQuality breakdown
- Expectation
- Net and operating margins stay near 27% over the next 12 months, keeping the peer quality rank high.
CounterMargins on insurance books can be flattered by investment gains and reserve releases, and revenue is already declining 1%, so margins may not be repeatable.
Geographic concentration in Japan at 53.0% ties results to one economy and currency, making a single-market shock the main risk to earnings.
↑ImprovingBear case
- Expectation
- Japan share of the business should not rise further and results should hold up through yen and Japanese rate moves.
CounterJapan is a mature, stable insurance market where Aflac has long operated, so the concentration may be a feature of its franchise rather than a flaw.
The share price of $123.89 sits above the $105.6 analyst target, a 14.8% overshoot, leaving no valuation upside and a negative reward-to-risk of -1.32.
→StableEstimated upside
- Expectation
- For the stock to justify its price, analyst targets must be raised toward or above the current price within 12 months.
CounterAnalyst targets lag price in strong rallies and forward P/E of 16.3x is not extreme for a high-quality insurer, so targets may simply be revised up.
Momentum is positive with rising on-balance volume and price above the 200-day average, but RSI of 73 and a price 4.9% from the 52-week high signal an extended move.
↓DeterioratingMomentum breakdown
- Expectation
- Price holds above the 200-day average through a normal pullback without RSI-driven reversal.
CounterOverbought readings often precede mean reversion, especially when the price already exceeds the analyst target.
Insiders sold about $76.0M over 90 days across 86 sales with zero purchases, a bearish signal despite being only 0.122% of market cap.
→StableNet value 90d
- Expectation
- Insider selling should taper and not accelerate as the stock sits near its highs.
CounterLarge sales count may reflect routine pre-scheduled compensation selling and the amount is tiny relative to market cap.
Per-dimension breakdown
Quality
6.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 5.6 |
| ROA | 2.1 |
| Gross margin | 6.2 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 3.6 |
| FCF quality | 7.3 |
| Moat | 5.9 |
| Piotroski F | 6.7 |
- ▸Strong margins: 27%
Growth
6.1/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 2.2 |
| EPS growth | 10.0 |
- ▸Declining revenue: -1%
Momentum
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Overbought (RSI 71)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
4.7/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.0 |
| Analyst rating | 5.0 |
| Price target | 4.1 |
Insider
4.6/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 6.3 |
| notable moves | 7.0 |
- ▸Notable insider selling — $75,969,172 (0.122% of mkt cap)
Peer rank
4.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.2 |
| quality rank | 8.0 |
| growth rank | 1.3 |
- ▸Best-in-class margins
Technical
4.0/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.3 |
| support resistance | 0.5 |
| 52w position | 9.3 |
| gap | 5.0 |
Risk (lower is worse)
7.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.7 |
| days to cover | 5.4 |
| volatility | 8.1 |
| put call | 8.5 |
| implied vol | 7.1 |
| max pain risk | 3.0 |
| beta | 9.7 |
| debt equity | 7.8 |
- ▸Above max pain $85
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 0.0 |
| earnings timing | 5.0 |
| surprise avg | 6.2 |
| dividend safety | 6.8 |
| news activity | 8.0 |
- ▸Earnings concerns: 1B/3M
- ▸Earnings today
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (6)
- MOMENTUM:6.7>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- ASYMMETRY:-1.5=NEGATIVE
- EARNINGS_PROXIMITY:0d<=7d
Warning (0)
none
Reward-to-Risk
-1.54
Upside
-15.7%
Downside
10.2%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:6.7>=5.5. Top dim: Risk (lower is worse) at 7.3; weakest: Technical at 4.0. No conviction either direction.
The strongest dimensions are Risk (lower is worse) at 7.3, Value at 7.0, and Momentum at 6.7; the weakest are Technical at 4.0, Peer rank at 4.4, and Insider at 4.6. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of -1.54 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Best In Class Insurance Margins
Trip ifNet margin falls below 20% from the current 27%.
- P2Japan Geographic Concentration Risk
Trip ifJapan share of concentration exceeds 60% from the current 53.0%.
- P3Price Above Analyst Target
Trip ifAnalyst target stays below $105.6 while price exceeds $130, widening the overshoot to more than 20%.
- P4Overbought Momentum Near Highs
Trip ifPrice falls below the 200-day moving average for 2 consecutive weeks.
- P5Heavy Insider Selling No Buying
Trip if90-day insider net selling exceeds $150M.